Home
>
National Drug Code (NDC)
>
Lotensin
Lotensin - 0078-0450-05 - (Benazepril Hydrochloride)
Drug Information of Lotensin
| Product NDC: | 0078-0450 |
| Proprietary Name: | Lotensin |
| Non Proprietary Name: | Benazepril Hydrochloride |
| Active Ingredient(s): | 40 mg/1 & nbsp; Benazepril Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lotensin
| Product NDC: | 0078-0450 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019851 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910625 |
Package Information of Lotensin
| Package NDC: | 0078-0450-05 |
| Package Description: | 100 TABLET in 1 BOTTLE (0078-0450-05) |
NDC Information of Lotensin
| NDC Code | 0078-0450-05 |
| Proprietary Name | Lotensin |
| Package Description | 100 TABLET in 1 BOTTLE (0078-0450-05) |
| Product NDC | 0078-0450 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Benazepril Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19910625 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | BENAZEPRIL HYDROCHLORIDE |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
